切换导航
News
All Journals
All Articles
Subscribe
Sign up for updates about the journal.
Subscribe
Sign in
Register
Exploration of Targeted Anti-tumor Therapy
切换导航
2.8
CiteScore
PubMed
Indexed
ESCI
Indexed
Submit Manuscript
About
About the Journal
Editorial Board
Editorial Policies
Newsletter
Contact Us
Articles
Special Issue
All Special Issues
Guest Editor Guidelines
For Authors
Author Instructions
Editorial Process
Article Processing Charge
Submit a Manuscript
For Reviewers
Peer Review Guidelines
Reviewer Acknowledgment
To Be a Reviewer
Focus
About
About the Journal
Editorial Board
Editorial Policies
Newsletter
Contact Us
Articles
Special Issue
All Special Issues
Guest Editor Guidelines
For Authors
Author Instructions
Editorial Process
Article Processing Charge
Submit a Manuscript
For Reviewers
Peer Review Guidelines
Reviewer Acknowledgment
To Be a Reviewer
Focus
Search
All Journals
Exploration of Medicine
Exploration of Targeted Anti-tumor Therapy
Exploration of Immunology
Exploration of Neuroprotective Therapy
Exploration of Digestive Diseases
Exploration of Neuroscience
Exploration of Musculoskeletal Diseases
Exploration of Drug Science
Exploration of Asthma & Allergy
Exploration of Foods and Foodomics
Exploration of Digital Health Technologies
Exploration of Cardiology
Exploration of BioMat-X
Exploration of Endocrine and Metabolic Diseases
All
Article Title
Abstract
Author
Keywords
Institution
Home
/
Exploration of Targeted Anti-tumor Therapy
/
Articles
/
t2
From:
Medicinal chemistry advances in targeting class I histone deacetylases
Table 2
Structures of clinically approved HDAC inhibitors
Name
Structure
Vorinostat
Tucidinostat
Romidepsin
Panobinostat
Belinostat
Return to article view
